Barely Significant
← all excerpts

The new era of AML therapy: current standards and emerging targets.

Int J Clin Oncol · 2026 · PMC13303667 · PMID 41995989

Europe PMCDOI
1
hedged sentence
0.1087
closest p · 2.2× alpha
0.1087
boldest claim

The sentences

showed a trendP = 0.1087not close (p > 0.1)
Although the AZA group showed a trend toward prolonged median OS (10.4 vs. 6.5 months; HR 0.85, P = 0.1087) without reaching the threshold for statistical significance, Europe and Japan granted approval based on survival benefits observed in sensitivity and domestic analyses [ 44 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.